Quarterly Balance Sheet

Carna Biosciences, Inc. - Filing #7313273

Concept As at
2024-06-30
As at
2023-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,026,030,000 JPY
2,889,101,000 JPY
Merchandise and finished goods
101,778,000 JPY
94,383,000 JPY
Work in process
8,711,000 JPY
12,390,000 JPY
Raw materials and supplies
36,987,000 JPY
33,367,000 JPY
Other
272,016,000 JPY
374,044,000 JPY
Current assets
3,544,519,000 JPY
4,191,484,000 JPY
Non-current assets
Property, plant and equipment
99,070,000 JPY
105,498,000 JPY
Property, plant and equipment
Intangible assets
679,000 JPY
1,091,000 JPY
Intangible assets
Investments and other assets
41,380,000 JPY
51,817,000 JPY
Investments and other assets
Non-current assets
141,130,000 JPY
158,407,000 JPY
Assets
3,685,650,000 JPY
4,349,891,000 JPY
Liabilities
Current liabilities
Income taxes payable
23,644,000 JPY
28,273,000 JPY
Other
19,334,000 JPY
36,349,000 JPY
Current liabilities
370,644,000 JPY
375,921,000 JPY
Non-current liabilities
Long-term borrowings
18,406,000 JPY
28,402,000 JPY
Asset retirement obligations
38,972,000 JPY
38,657,000 JPY
Other
42,310,000 JPY
29,375,000 JPY
Non-current liabilities
99,689,000 JPY
96,435,000 JPY
Liabilities
470,333,000 JPY
472,356,000 JPY
Net assets
Shareholders' equity
Share capital
2,258,599,000 JPY
2,076,474,000 JPY
Capital surplus
6,009,808,000 JPY
5,827,683,000 JPY
Retained earnings
-5,169,504,000 JPY
-4,075,386,000 JPY
Treasury shares
-222,000 JPY
-222,000 JPY
Shareholders' equity
3,098,680,000 JPY
3,828,549,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-3,148,000 JPY
-2,722,000 JPY
Deferred gains or losses on hedges
27,374,000 JPY
JPY
Valuation and translation adjustments
116,635,000 JPY
48,986,000 JPY
Net assets
3,215,316,000 JPY
3,877,535,000 JPY
Liabilities and net assets
3,685,650,000 JPY
4,349,891,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.